2nd Quarter - Report

NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH for NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Animals ANI

FY25/26 Approps, Permitting, Support for biomedical research

LobbyistCovered position, as disclosed
MATTHEW R BAILEY —
BRANDON MORTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Transportation, Dept of (DOT); U.S. Fish & Wildlife Service (USFWS); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA)

Transportation TRA

Transportation of research animals

LobbyistCovered position, as disclosed
MATTHEW R BAILEY —
BRANDON MORTON —

Contacted: HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); SENATE; Veterans Affairs, Dept of (VA); Vice President of the U.S.; Transportation, Dept of (DOT); U.S. Fish & Wildlife Service (USFWS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Treasury, Dept of; Agriculture, Dept of (USDA)

Budget/Appropriations BUD

FY25/26 support

LobbyistCovered position, as disclosed
MATTHEW R BAILEY —
BRANDON MORTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Need for continued biomedical research with animal models

LobbyistCovered position, as disclosed
MATTHEW R BAILEY —
BRANDON MORTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.